|Articles|October 1, 2001

Lack of trust in staff could hurt bottom line

How much do you trust your staff? Why does it matter? Trust affects thebottom line - the way you treat employees is the way they will treat patients.If it's acceptable that a company or manager need not keep promises, youcan almost guarantee employees won't be keeping promises to patients either.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!

Related Content

Day 4 Recap: Elevate-Derm Fall Conference

ByKaitlyn Bader, Assistant Managing Editor

November 16th 2025

Improving Outcomes in Acne, Hidradenitis Suppurativa, and Vitiligo Through Treatment Advancements

ByBuchi Neita, MCMSc, PA-C,Kaitlyn Bader, Assistant Managing Editor

November 16th 2025

Psychodermatology’s Role in Strengthening Therapeutic Connections

ByPatricia Delgado, DNP, AGPCNP, DCNP, PMHNP,Kaitlyn Bader, Assistant Managing Editor

November 16th 2025

Rethinking Differential Diagnoses Through Peer Connection

ByLisa Weiss, MMSc, PA-C,Justin Love, PA-C,Kaitlyn Bader, Assistant Managing Editor

November 16th 2025

Is It Just a Rash? Key Issues in Diagnosing and Treating Cutaneous Lupus

ByHeidi Anne Duerr, MPH

November 16th 2025

Latest CME

Video

‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis

Raj Chovatiya, MD, PhD, MSCI, FAAD; Michael Rubio, PA-C, MMSc

Video

Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis

Joseph Gorelick, MSN, FNP-C

Video

Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?

Brad P. Glick, DO, MPH, FAAD

Multimedia

Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management

Hilary Baldwin; Neal Bhatia, MD

Video

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

In-Person Event

Revolutionizing Atopic Dermatitis (RAD) Conference 2026

June 17-19, 2026

Register now!

Video

Clinical Consultations™: Providing Holistic Care for Complex Cases of Psoriasis with Cardiovascular Comorbidities

Brittany Weber MD, PhD, FACC, FAHA; Lourdes M. Perez-Chada MD, MMSc

Video

Understanding Topical Steroid Withdrawal (TSW) in Patients With Atopic Dermatitis (AD)

Diego Ruiz Dasilva, MD, FAAD; Brad Glick, DO, MPH. FAAD; Peter Lio, MD

Video

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Andrew Alexis, MD, MPH; Leon Kircik, MD

Video

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Johann Gudjonsson, MD, PhD; Christopher Bunick, MD, PhD

Video

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Andrew F. Alexis, MD, MPH; Chesahna Kindred, MD, MBA, FAAD

Video

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Douglas DiRuggiero, DMSc, MHS, PA-C; Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP

Multimedia

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Jerry Bagel, MD, MS

Video

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hadar Lev-Tov, MD; Martina Porter, MD

Lack of trust in staff could hurt bottom line

Newsletter

Related Content

Day 4 Recap: Elevate-Derm Fall Conference

Improving Outcomes in Acne, Hidradenitis Suppurativa, and Vitiligo Through Treatment Advancements

Psychodermatology’s Role in Strengthening Therapeutic Connections

Rethinking Differential Diagnoses Through Peer Connection

Is It Just a Rash? Key Issues in Diagnosing and Treating Cutaneous Lupus

Latest CME

‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis

Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis

Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?

Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Revolutionizing Atopic Dermatitis (RAD) Conference 2026

Clinical Consultations™: Providing Holistic Care for Complex Cases of Psoriasis with Cardiovascular Comorbidities

Understanding Topical Steroid Withdrawal (TSW) in Patients With Atopic Dermatitis (AD)

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Trending on Dermatology Times

Improving Outcomes in Acne, Hidradenitis Suppurativa, and Vitiligo Through Treatment Advancements

Psychodermatology’s Role in Strengthening Therapeutic Connections

Day 4 Recap: Elevate-Derm Fall Conference

Treatment Plan Expectations and Previewing the 2026 Pipeline

Expert Tips for Treating Vitiligo Shared at Elevate-Derm Conference